Simvastatin initiated early after heart transplantation: 8-year prospective experience.
about
Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizonsIdentification of activators of ERK5 transcriptional activity by high-throughput screening and the role of endothelial ERK5 in vasoprotective effects induced by statins and antimalarial agentsHMG-CoA reductase inhibitors in kidney transplant recipients receiving tacrolimus: statins not associated with improved patient or graft survivalCoronary microvasculopathy in heart transplantation: Consequences and therapeutic implications.The complex interplay between cholesterol and prostate malignancy.Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.Guidelines for the treatment and management of new-onset diabetes after transplantation.Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipientsEarly Subretinal Allograft Rejection Is Characterized by Innate Immune Activity.Immunosuppression for heart transplantation: where are we now?Treatment of allograft vasculopathy in heart transplantation.Heart retransplantation.Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomographyHyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.Clinical utility of intravascular ultrasound in the assessment of coronary allograft vasculopathy: a review.Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature.Endothelial dysfunction and cardiac allograft vasculopathy.Mechanical circulatory assist as a bridge to heart retransplantation in adolescents.Diagnosis and management of coronary allograft vasculopathy in children and adolescents.Novel therapeutic and diagnostic management of heart transplant patients.Improvements in Dutch heart transplant patient outcomes: lessons for the future.Impact of hyperlipidemia on alloimmunity.Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine.Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis.Statins demonstrate a broad anti-cytomegalovirus activity in vitro in ganciclovir-susceptible and resistant strains.Evolving concepts and treatment strategies for cardiac allograft vasculopathy.Simvastatin reduces leucocyte- and platelet-endothelial cell interaction in murine antigen-induced arthritis in vivo.Clopidogrel-Precipitated Rhabdomyolysis in a Stable Heart Transplant Patient
P2860
Q26752168-BB9FB8D0-28AD-44B6-80D9-016DCD39BE4DQ27302392-D2AB4F50-A238-4EE7-ACB8-32D8AC5A40F8Q33548525-BF9BDFEC-D505-4F94-95B4-4DEE4322135FQ33891755-856FCECD-BBCE-402E-BF9A-9612F820D162Q35137013-AF8FD9BB-5ED3-43E4-A389-3DE67986CAE5Q35139244-61F23527-8C98-42A8-999F-F26159ADF93DQ36118632-6F762CDF-3CBF-4B6D-9CED-6E47AC88F0D3Q36177467-1E6ACE6F-117E-4169-9176-AF50CE3A9E7BQ36255088-BCFCCAC2-CF10-488A-9F6C-95B268CBFAC4Q36433573-A646948C-61B3-402D-A06E-976C84E3A52DQ36655174-CE238F3E-36DE-4376-87B4-69948B171A66Q36886336-6C44308E-17A6-405D-9EB4-8136BCF19E3FQ37136440-BA598AB6-B96B-4AFE-A0D5-994149BE19DFQ37247613-19B9AF77-C037-424B-A693-5EA6170916D7Q37804420-81F0893C-D4A1-4C51-993C-60E391B88518Q37851481-F26591B6-91E7-4D3C-A910-1C17FB19E4D9Q37853958-CD67CA5D-F5F1-4C09-AFFB-7D57A945C357Q38058477-DBC2D815-5D66-4409-8EC9-9F2FCA343885Q38233554-107F7B03-3033-4926-BBC4-16267A0CC998Q38300629-EF8E4B7B-6148-46AA-8A86-BFCEF7BA99FAQ38614686-65C43FEE-F97B-47DF-8C08-85478BC3F2B8Q39002097-5E9A6F4F-10D6-4B74-9285-77C5F87AE06AQ39041394-A81E5FB4-5F54-441A-B279-171AFBE1EEDFQ39231307-0C85B3D5-6433-4832-B49A-AFBAE795D53EQ41482355-C7D3EFA2-B760-4970-8771-34A42FA707A5Q42208366-7C239851-F3A8-420C-BA8C-5EF10B8E2BE6Q47613394-347BB80E-75A1-40FA-B921-5653ECEE8E4EQ51140338-FF6483A8-C08E-405B-83F4-44BA8ADC6A7AQ59314612-CE99F1CE-C24D-4796-BBA4-F0D0727D4A0F
P2860
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@ast
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@en
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@nl
type
label
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@ast
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@en
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@nl
prefLabel
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@ast
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@en
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@nl
P2093
P1433
P1476
Simvastatin initiated early after heart transplantation: 8-year prospective experience.
@en
P2093
Bruno Meiser
Bruno Reichart
Dietrich Seidel
Dorothea Nagel
Gerhard Steinbeck
Karl Krobot
Klaus Wenke
Wolfgang von Scheidt
P356
10.1161/01.CIR.0000043241.32523.EE
P407
P577
2003-01-01T00:00:00Z